ID

38126

Description

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01788839

Lien

https://clinicaltrials.gov/show/NCT01788839

Mots-clés

Versions (1)
  1. 20/09/2019 20/09/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

20 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT01788839

Anglais

Eligibility Breast Cancer NCT01788839

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject inclusion criteria for cohort of premenopausal women with early stage breast cancer and lymphoma
Description

Premenopausal state | Early-Stage Breast Carcinoma | Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C2986665
UMLS CUI [3]
C0024299
premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant or had at least one menstrual period in the last 12 months
Description

Premenopausal state | Age | Pregnancy | Menstrual cycle Quantity Timespan

Type de données

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0032961
UMLS CUI [4,1]
C0025329
UMLS CUI [4,2]
C1265611
UMLS CUI [4,3]
C0872291
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
Description

Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0474926
UMLS CUI [3]
C1515119
UMLS CUI [4,1]
C1708063
UMLS CUI [4,2]
C1276305
UMLS CUI [4,3]
C1332225
breast cancer patients with any receptor type
Description

Breast Carcinoma | Receptor Type Any

Type de données

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C0597357
UMLS CUI [2,2]
C0332307
UMLS CUI [2,3]
C1552551
english speaking
Description

Able to speak English Language

Type de données

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
able to participate in the informed consent process
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
subject inclusion criteria for cohort of postmenopausal women with early stage breast cancer and lymphoma
Description

Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C2986665
UMLS CUI [3]
C0024299
postmenopausal women at time of diagnosis > age 50 who have been without period for ≥ 2 years.
Description

Postmenopausal state | Age | Menstruation Absent Duration

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C0025344
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0449238
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
Description

Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0474926
UMLS CUI [3]
C1515119
UMLS CUI [4,1]
C1708063
UMLS CUI [4,2]
C1276305
UMLS CUI [4,3]
C1332225
breast cancer patients with any receptor type
Description

Breast Carcinoma | Receptor Type Any

Type de données

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C0597357
UMLS CUI [2,2]
C0332307
UMLS CUI [2,3]
C1552551
english speaking
Description

Able to speak English Language

Type de données

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
able to participate in the informed consent process
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject exclusion criteria for both pre and postmenopausal women with early stage breast cancer and lymphoma
Description

Exclusion Criteria | Premenopausal state | Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0232969
UMLS CUI [3]
C0232970
UMLS CUI [4]
C2986665
UMLS CUI [5]
C0024299
active secondary cancer requiring cytotoxic chemotherapy
Description

Secondary Neoplasm Requirement Cytotoxic Chemotherapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C2939419
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0677881
prior systemic treatment for a malignancy
Description

Systemic therapy Malignant Neoplasms

Type de données

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0006826
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT01788839

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Premenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject inclusion criteria for cohort of premenopausal women with early stage breast cancer and lymphoma
boolean
C0232969 (UMLS CUI [1])
C2986665 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Premenopausal state | Age | Pregnancy | Menstrual cycle Quantity Timespan
Item
premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant or had at least one menstrual period in the last 12 months
boolean
C0232969 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0032961 (UMLS CUI [3])
C0025329 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C0872291 (UMLS CUI [4,3])
Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma
Item
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3])
C1708063 (UMLS CUI [4,1])
C1276305 (UMLS CUI [4,2])
C1332225 (UMLS CUI [4,3])
Breast Carcinoma | Receptor Type Any
Item
breast cancer patients with any receptor type
boolean
C0678222 (UMLS CUI [1])
C0597357 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Informed Consent
Item
able to participate in the informed consent process
boolean
C0021430 (UMLS CUI [1])
Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject inclusion criteria for cohort of postmenopausal women with early stage breast cancer and lymphoma
boolean
C0232970 (UMLS CUI [1])
C2986665 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Postmenopausal state | Age | Menstruation Absent Duration
Item
postmenopausal women at time of diagnosis > age 50 who have been without period for ≥ 2 years.
boolean
C0232970 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0025344 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0449238 (UMLS CUI [3,3])
Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma
Item
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3])
C1708063 (UMLS CUI [4,1])
C1276305 (UMLS CUI [4,2])
C1332225 (UMLS CUI [4,3])
Breast Carcinoma | Receptor Type Any
Item
breast cancer patients with any receptor type
boolean
C0678222 (UMLS CUI [1])
C0597357 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Informed Consent
Item
able to participate in the informed consent process
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Exclusion Criteria | Premenopausal state | Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject exclusion criteria for both pre and postmenopausal women with early stage breast cancer and lymphoma
boolean
C0680251 (UMLS CUI [1])
C0232969 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C2986665 (UMLS CUI [4])
C0024299 (UMLS CUI [5])
Secondary Neoplasm Requirement Cytotoxic Chemotherapy
Item
active secondary cancer requiring cytotoxic chemotherapy
boolean
C2939419 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0677881 (UMLS CUI [1,3])
Systemic therapy Malignant Neoplasms
Item
prior systemic treatment for a malignancy
boolean
C1515119 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial